(Q51675239)
Statements
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer. (English)
Yasushi Yatabe
Tatsuya Yoshida
Yuko Oya
Kosuke Tanaka
Junichi Shimizu
Yoshitsugu Horio
Hiroaki Kuroda
Yukinori Sakao
Toyoaki Hida
27 June 2016
3383-3389